We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




First Genomic Research Studies Published Utilizing Collaborative Cross Mice

By LabMedica International staff writers
Posted on 04 Aug 2011
Print article
The Collaborative Cross (CC) represents a large collection of new inbred mouse strains created by the mouse genetics community aimed at transforming the study of complex genetic traits and diseases. Derived from classical inbred strains and wild-derived strains, the CC captures nearly 90% of known genetic variation in laboratory mice, far exceeding more commonly used inbred strains.

The CC is a tool to integrate studies of gene function and gene networks, allowing the prediction and testing of biologic models based on the whole organism, vital to the development of customized therapies for humans. The journal Genome Research has published three articles online utilizing strains from the emerging Collaborative Cross mouse strains.

The first study concerns Collaborative Cross strains facilitate mapping of causative loci; In this work, published in the April 2011 issue of Genome Research, Dr. Katherine I. Fisher-Aylor and colleagues from the California Institute of Technology (Caltech; Pasadena, USA), Systemix Institute (Redmond, WA, USA), and the Lawrence Berkeley National Laboratory (Berkeley, CA, USA) performed an experiment called the pre-CC study, the first genetic data and analysis from the emerging strains of the CC. Their research revealed that the genomes of CC strains are genetically diverse and contain balanced contributions from each founding strain.

Highlighting the statistical power provided by the CC, Dr. Aylor and colleagues utilized ancestry data of the CC strains to map genetic loci for a Mendelian trait (white head-spotting), a complex trait (body weight), and a molecular trait (gene expression in the liver), demonstrating the ancestry-based approach to be superior to established marker-based methods for trait loci discovery.

The development of the Collaborative Cross presents a unique opportunity to investigate how the breeding of inbred strains affects genetic structure and the diversity of phenotypes. In another article, published online July 6, 2011, Dr. Vivek M. Philip and colleagues from the Systems Genetics Group, biosciences division, Oak Ridge National Laboratory (Oak Ridge, TN, USA) and the University of Tennessee (Knoxville, TN, USA) have evaluated the range of many traits in late inbreeding populations of the CC, including such phenotypes as body weight, tail length, heart weight, and behavioral traits. In spite of the influence of breeding selection in the CC lines, detection of major genetic loci regulating trait variation remained possible. This analysis revealed the scope of phenotypic variation that will be present in the finished strains of the CC.

Aspergillosis is a serious disease in humans, particularly in immune-compromised individuals, caused by infection with the fungus Aspergillus. The mouse has been an important model for studying Aspergillus infection, but classical laboratory strains of mice used in these studies arose from a small set of founders and lack most of the genetic variation present in wild mice, limiting researchers’ ability to identify additional genetic loci relevant to disease.

In the last study, published online April 14, 2011, issue of Genome Research, Dr. Caroline Durrant, from Wellcome Trust Center for Human Genetics, University of Oxford, UK), and colleagues from the department of clinical microbiology and immunology, Sackler Faculty of Medicine, Tel Aviv University (Tel Aviv, Israel), and the department of genetics, University of North Carolina (Chapel Hill, NC, USA) utilized inbred mouse strains from the Collaborative Cross, exploiting the genetic contribution of wild-derived strains, to identify novel loci that confer susceptibility to infection with the fungus Aspergillus.

By integrating genetic variation data from the genomes of the founding strains of the CC, Dr. Durrant and colleagues additionally modified the genetic loci associated with Aspergillus susceptibility to suggest specific candidate genes.

Related Links:
California Institute of Technology
Ridge National Laboratory
Wellcome Trust Center for Human Genetics



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Amoebiasis Test
ELI.H.A Amoeba
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.